Changliang Yang

Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab

Jingjing Liu, Shuang Li, Shuang Zhang et al. · Journal of Clinical Laboratory Analysis · 2019 · 357 citations · Full text

Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors

Ying Cheng, Lixia Ma, Ying Liu et al. · Lung Cancer · 2020 · 32 citations

Oncology, Novel Therapy, Medicine +8

Factors related to rapid progression of non‐small cell lung cancer in Chinese patients treated using single‐agent immune checkpoint inhibitor treatment

Liang Zhang, Lianwei Bai, Xianhong Liu et al. · Thoracic Cancer · 2020 · 26 citations · Full text

Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC

Ting Deng, Huiya Wang, Changliang Yang et al. · Frontiers in Immunology · 2022 · 14 citations · Full text

Heat Shock Protein 27, a Novel Regulator of Transforming Growth Factor β Induced Resistance to Cisplatin in A549 Cell

Zhicheng Huang, Changliang Yang, Shuangyan Sun et al. · Pharmacology · 2017 · 12 citations

Molecular Biology, Cell Proliferation, Cell Growth +20